|
Neoadjuvant endocrine therapy Clinical Trials
2 actively recruiting trials across 2 locations
Also known as: NET
Pipeline
Phase 2: 2
Top Sponsors
- Memorial Sloan Kettering Cancer Center1
- George Washington University1
Indications
- Breast Cancer2
- Cancer2
- Carcinoma Breast1
- ER+ Breast Cancer1
- Breast Cancer Stage III1
Washington D.C., District of Columbia1 trial
Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)
George Washington-Medical Faculty Associates
Phase 2
Basking Ridge, New Jersey1 trial
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.